Skip to main content

Table 1 Characteristics of MetS cases (n = 92) and controls (n = 105)

From: The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study

Characteristic

MetS cases (n = 92)

Controls (n = 105)

p

Age, years, mean ± S.D

45.33 ± 9.56

44.74 ± 9.67

0.672c

BMI, Kg/m2, mean ± S.D

37.64 ± 5.7

26.07 ± 5.4

<0.001 a

Waist (cm),mean ± S.D

119.76 ± 10.96

89.68 ± 13.87

<0.001 a

TC (mg/dl), mean ± S.D

182.12 ± 44.52

165.42 ± 22.74

0.001 a

TAG (mg/dl), mean ± S.D

177.45 ± 84.06

110.06 ± 33.25

<0.001 a

HDL-C (mg/dl), mean ± S.D

38.51 ± 9.33

44.76 ± 8.07

<0.001 a

LDL-C (mg/dl), mean ± S.D

108.11 ± 39.44

98.58 ± 20.31

0.038 a

FPG (mg/dl), median(min-max)

161(64-361)

89(60-323)

<0.001 b

FSI(μIU/mL), median(min-max)

13.39(2.9–30.3)

8.5(1-30)

<0.001 b

HOMA-IR, median(min-max)

4.48(0.77–20.46)

1.9(0.2-23.93)

<0.001 b

QUICKI, mean ± S.D

0.31 ± 0.04

0.35 ± 0.05

<0.001 a

FTO (rs9939609)

 TT, n(%)

24 (26.1)

43 (41)

 

 AT, n(%)

50 (54.4)

54 (51.4)

 

 AA, n(%)

18 (19.5)

8 (7.6)

0.014 c

  1. Values are mean ± SD for parametric variables or median (range) for non-parametric variables. BMI Body mass index, WC Waist circumference, T.C Total cholesterol, TAG Triacylglycerol, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, FPG Fasting plasma glucose, FSI Fasting serum insulin
  2. aIndependent T- test, two-sided p value >0.05 non-significant
  3. bMann–Whitney U test, two sided p value >0.05 non-significant
  4. cChi-square test, two-sided p value >0.05 non-significant